Table 3:
Distribution of ER
β
and PR in benign and malignant mammary tumors.
Tumor type
ER
β
+
PR+
ER
β
+
PR−
ER
β
−
PR+
ER
β
−
PR−
Total
Benign
5 (45.45%)
4 (36.36%)
1 (9.09%)
1 (9.09%)
11
Malignant
6 (33.33%)
8 (44.44%)
3 (16.67%)
1 (5.56%)
18
Total
11
12
4
2
29